AIP
OCEA

Ameritas Investment Partners’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Ameritas Investment Partners’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-717
Closed -$2.71K – 3254
2024
Q1 		$2.71K Hold
717
– – ﹤0.01% 3012
2023
Q4 		$473 Hold
717
– – ﹤0.01% 3082
2023
Q3 		$2.8K Hold
717
– – ﹤0.01% 3047
2023
Q2 		$4.31K Buy
+717
New +$4.2K ﹤0.01% 3043

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameritas Investment Partners's OCEA Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2024, closing a stake of 717 shares — an estimated $2.71K sold.

Ameritas Investment Partners first reported a position in OCEA in Q2 2023 and held it in 4 quarters. The position peaked at $4.31K in Q2 2023. 36 funds tracked by Wall St. Rank hold OCEA as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 717 Ocean Biomedical, Inc. Common Stock shares in Q2 2024, an estimated $2.71K.
  • Ameritas Investment Partners first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Ameritas Investment Partners's Ocean Biomedical, Inc. Common Stock position peaked at $4.31K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.